Home
>
National Drug Code (NDC)
>
DOXOrubicin Hydrochloride
DOXOrubicin Hydrochloride - 53150-315-01 - (DOXOrubicin Hydrochloride)
Drug Information of DOXOrubicin Hydrochloride
| Product NDC: | 53150-315 |
| Proprietary Name: | DOXOrubicin Hydrochloride |
| Non Proprietary Name: | DOXOrubicin Hydrochloride |
| Active Ingredient(s): | 50 mg/25mL & nbsp; DOXOrubicin Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DOXOrubicin Hydrochloride
| Product NDC: | 53150-315 |
| Labeler Name: | Amneal-Agila, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200901 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130430 |
Package Information of DOXOrubicin Hydrochloride
| Package NDC: | 53150-315-01 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (53150-315-01) > 25 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of DOXOrubicin Hydrochloride
| NDC Code | 53150-315-01 |
| Proprietary Name | DOXOrubicin Hydrochloride |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (53150-315-01) > 25 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 53150-315 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOXOrubicin Hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130430 |
| Marketing Category Name | ANDA |
| Labeler Name | Amneal-Agila, LLC |
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
| Strength Number | 50 |
| Strength Unit | mg/25mL |
| Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
